Oct 20 (Reuters) – AstraZeneca said on Tuesday that it is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals, among other
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: BAYERN MUNICH ASSISTANT COACH AARON DANKS AND FORWARD SERGE GNABRY TALKING ABOUT ARSENAL…
(Adds background, details, quote from paragraph 2) LONDON, Oct 20 (Reuters) - British police said…
By Caroline Valetkevitch and Shashwat Chauhan Oct 20 (Reuters) - US stocks rose as oil…
By Akash Sriram Oct 20 (Reuters) - AI meeting-transcription company Otter.ai said on Tuesday it…
Oct 20 (Reuters) - * RXMP THERAPEUTICS: DARPA AWARDS UP TO $10.7 MILLION CONTRACT TO…
VIDEO SHOWS: BAYERN MUNICH ASSISTANT COACH AARON DANKS AND FORWARD SERGE GNABRY TALKING ABOUT ARSENAL…